Bath & Body Works, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed a Schedule 13G, reporting beneficial ownership of 7,641,815 shares, representing 3.79% of Bath & Body Works, Inc. common stock.
NYSE
Vanguard Capital Management has reported beneficial ownership of 10,720,033 shares, representing 5.32% of the outstanding common stock of Bath & Body Works Inc.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 7.53% in Bath & Body Works Inc. common stock as of March 31, 2026.
NYSE
FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 10.4% of Bath & Body Works Inc. common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Bath & Body Works Inc. following an internal realignment.
NYSE
AQR Capital Management, LLC and its parent holding company have reported a beneficial ownership of 5.59% in Bath & Body Works, Inc. common stock.
NYSE
FMR LLC and Abigail P. Johnson have reported an 8.3% beneficial ownership stake in Bath & Body Works Inc., holding over 17 million shares of common stock.
NYSE
Victory Capital Management, Inc. has reported a 4.08% beneficial ownership stake in Bath & Body Works, Inc. common stock, held in the ordinary course of business.
NYSE
SCHEDULE 13G/A: T. Rowe Price Discloses 0.6% Stake in Bath & Body Works
T. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, reporting a 0.6% beneficial ownership stake in Bath & Body Works Inc.
NYSE
Victory Capital Management, Inc. has increased its beneficial ownership in Bath & Body Works, Inc. to 6.04% of common stock.
NYSE
Victory Capital Management, Inc. has reported a 6.04% beneficial ownership stake in Bath & Body Works, Inc. common stock.
NYSE
FMR LLC and Abigail P. Johnson disclose a passive 5.9% beneficial ownership stake in Bath & Body Works Inc. common stock.
NYSE
T. Rowe Price Investment Management, Inc. has disclosed a beneficial ownership of 5.1% of Bath & Body Works Inc.'s common stock, held for investment purposes.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, disclosing its beneficial ownership of 8.8% of Bath & Body Works, Inc.'s common stock as of March 31, 2025.